RT @DrugsJournal: Our 9th most downloaded article in #50YearsofDrugs is this article https://t.co/4T9D1spXDo by Giorgio Cruccu and colleagu…
RT @DrugsJournal: Our 9th most downloaded article in #50YearsofDrugs is this article https://t.co/4T9D1spXDo by Giorgio Cruccu and colleagu…
Our 9th most downloaded article in #50YearsofDrugs is this article https://t.co/4T9D1spXDo by Giorgio Cruccu and colleagues from Sapienza University on Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia #pain
RT @RevistaMFSamfyc: Opciones farmacológicas actuales e innovadoras para tratar la neuralgia del trigémino típica y atípica https://t.co/7h…
Opciones farmacológicas actuales e innovadoras para tratar la neuralgia del trigémino típica y atípica https://t.co/7hlfkA7baC PMID 30178160
RT @GavinGiovannoni: Are you a carbamazepine zombie? It is the downside of treating trigeminal neuralgia with the drug. This review highlig…
RT @GavinGiovannoni: Are you a carbamazepine zombie? It is the downside of treating trigeminal neuralgia with the drug. This review highlig…
RT @GavinGiovannoni: Are you a carbamazepine zombie? It is the downside of treating trigeminal neuralgia with the drug. This review highlig…
RT @GavinGiovannoni: Are you a carbamazepine zombie? It is the downside of treating trigeminal neuralgia with the drug. This review highlig…
Are you a carbamazepine zombie? It is the downside of treating trigeminal neuralgia with the drug. This review highlights current and innovative new treatments for trigeminal neuralgia. Could vixotrigine be the game-changer? #NeuroSpeak #ClinicSpeak https:
RT @reneroblesce: Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia. A new, better tolerat…
RT @reneroblesce: Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia. A new, better tolerat…
Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia. A new, better tolerated, Nav1.7 selective state-dependent, sodium channel blocker (vixotrigine) is under development https://t.co/CkbIGEAq8U
Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia. - PubMed - NCBI https://t.co/dyhYEikbEk